SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008086
Filing Date
2022-05-10
Accepted
2022-05-10 16:01:52
Documents
13
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K capr-20220510x8k.htm   iXBRL 8-K 39439
2 EX-99.1 capr-20220510xex99d1.htm EX-99.1 93940
  Complete submission text file 0001558370-22-008086.txt   260250

Data Files

Seq Description Document Type Size
3 EX-101.SCH capr-20220510.xsd EX-101.SCH 3022
4 EX-101.LAB capr-20220510_lab.xml EX-101.LAB 15410
5 EX-101.PRE capr-20220510_pre.xml EX-101.PRE 9798
7 EXTRACTED XBRL INSTANCE DOCUMENT capr-20220510x8k_htm.xml XML 4688
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 22909429
SIC: 2834 Pharmaceutical Preparations